Constellation Brands (STZ)
$207.34
0.00 (0.00%)
STZ Stock Quote Delayed 15 Minutes
Previous Close
$207.34
Market Cap
34.80B
PE Ratio
15.54
EPS
13.34
Volume (Avg. Vol.)
Day's Range
207.34 - 207.34
52-Week Range
150.37 - 228.91
Dividend & Yield
2.74 (1.32%)
STZ Stock Predictions, Articles, and Constellation Brands News
Leadership Transition Issues Exacerbate to CGC Stock Woes
Canopy Growth continues to have issues with its leadership transition. Because of this the price of CGC stock has declined.
Keep an Eye on Canopy Growth Stock, but Don’t Buy It Just Yet
Shares of Canopy Growth stock have been struggling immensely over the last few months. However, CGC has some new momentum.
Constellation Brands Stock: What the Bulls are Smoking
Constellation CEO Bill Newlands insists people will pay more for quality products, whether that's beer, wine, booze or pot.
Worries Mount as Aurora Cannabis Stock Nears 52-Week Lows
Like other cannabis investments, Aurora Cannabis stock has suffered incredible volatility recently. In order to generate some confidence, ACB stock must start justifying its rich premium.
3 Big Stock Charts for Tuesday: TechnipFMC PLC, Vertex Pharmaceuticals and Constellation Brands
The stock charts of FTI, VRTX and STZ are knocking on the doors of major moves, even if the broad market isn't.
It’s Just a Matter of Time Before Canopy Growth’s Woes Hit Constellation
Canopy Growth invested ahead of marijuana market growth that has yet to develop, and Constellation Brands invested in CGC.
CGC Stock Is a Drag on the Rest of the Cannabis Sector
CGC stock is at a crucial technical juncture as Canopy Growth approaches the release of last quarter's numbers. Other pot stocks are apt to follow its lead.
3 Potential Catalysts That Could Send Tilray Shares Soaring
Despite falling from the highs, TLRY has potential. Here are three potential positive catalysts that could unlock Tilray's potential.
Aphria Stock Needs Support It Won’t Get to Keep from Dropping More
Aphria stock hasn't been trading well, like most of its cannabis stock peers. Is the stock undervalued or unhealthy at current levels?
Owning Hexo Stock Requires a Longer-Term Mindset
HEXO stock is losing ground like most other pot stocks, but management is most definitely building a differentiated company.
Did Cronos Group Just Become a Big-Time Sell?
Although CRON stock has held up better than some of its peers, sector volatility appears ready to take it down too.
The Firing of Canopy Growth’s co-CEO Is Only Part of the Case Against CGC Stock
CGC stock is suddenly a liability after the industry's problems started to weigh on CGC stock price in recent weeks
3 Reasons Linton’s Firing was Good News for Canopy Stock
Canopy Growth saw its shares fall 5% last week after CEO Bruce Linton was fired. But Linton's firing is good news for CGC stock going forward.
CGC Stock Reacts to Canopy Co-CEO’s Ouster
CGC stock continues downward trend that started with disappointing earnings and continued with ouster of founder and Co-CEO Bruce Linton.
Sorry Bulls, Canopy Stock Is Still a Short
Following a disappointing earnings report, an upheaval in management and continued weakness on the price chart, CGC stock remains a short.
Tilray Prepares a Second Act That Could Rekindle TLRY Stock
Tilray stock has conspicuously taken a beating relative to the major cannabis players, but the underlying company's presence in the U.K. could change the narrative.
3 Big Stock Charts for Monday: KeyCorp, Procter & Gamble and Mohawk Industries
The stock charts of KeyCorp, Procter & Gamble and Mohawk Industries are ready to start the new trading week out with a bang.
5 Top Stock Trades for Monday: STZ, C, UBER
STZ beat on earnings, and the Fed approved higher dividends and buybacks for the bank stocks. Here are the top stock trades heading into next week.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
C
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
